While only 2% are ready, most companies expect productivity gains of 10-40% with Enterprise AI: Infosys Research (1)
Prepare data infrastructure for AI: Data health is crucial for AI success but remains a challenge. Only 10% of the companies ...
5GAA: Berlin Technology Demonstrations Highlight Life-Saving Potential of Latest Cellular Vehicle-to-Everything Tech
The 5G Automotive Association (5GAA) last week demonstrated the latest innovations in the Cellular Vehicle-to-Everything (C-V2X) technology family to help achieve "Vision Zero" for all road users. The ...
SUSTAINABLE MARKETS INITIATIVE UNVEILS SUPPORT TO COMMONWEALTH MEMBER STATES AT CHOGM (1)
Marine Mangrove Sanctuary: In collaboration with Rotary International and Space X, the SMI is launching a Marine Mangrove ...
Infosys Unveils Small Language Models - Infosys Topaz BankingSLM and Infosys Topaz ITOpsSLM - Built on NVIDIA AI Stack
The small language models will be integrated into products and services as part of Infosys Topaz offerings to provide ...
Infosys Collaborates with University of Cambridge to Establish an AI Lab in London, Unveils New and Expanded Living Lab
The Infosys Living Labs located in London's world-renowned banking district of Canary Wharf will enable a confluence of ...
Infosys Expands Strategic Collaboration with Meta: Unveils Center of Excellence to Drive Enterprise AI Innovation throug
Infosys (NSE: INFY), (BSE: INFY), (NYSE: INFY), a global leader in next-generation digital services and consulting, today ...
Infosys: Strong performance with broad based revenue growth in CC of 3.1% sequentially and 3.3% YoY (1)
Margin guidance retained at 20%-22% BENGALURU, India, Oct. 17, 2024 /PRNewswire/ -- Infosys (NSE: INFY) (BSE: INFY) (NYSE: ...
Election integrity at stake: Report highlights governance issues in the US
Voter turnout, a crucial metric of engagement, lags behind other advanced democracies, raising concerns about public ...
Chiesi launches innovation platform focused on partnership and patient care: The Impulse
Chiesi Group, a research-oriented international biopharmaceutical group, is proud to announce the official launch of The Impulse, an innovation platform designed to accelerate bold ideas and ...
First participants enrolled in first-in-human Phase I clinical trial with nociceptin (NOP) receptor agonist
Today, Grünenthal announced that the first participants have been enrolled in a first-in-human Phase I clinical trial for a nociceptin (NOP) receptor agonist. The trial will include 90 healthy ...
Notimerica7d
PIONIERKRAFT recauda una alta cantidad de siete cifras en la ronda de financiación Serie A
Munich-based energy start-up PIONIERKRAFT has raised a high seven-figure amount in its Series A financing round, led by First ...